Introducing Pharmaplasia

Unlike any other book about the pharmaceutical industry, Mike Wokasch a 30 year industry veteran,  delves into the causes of the industry’s current state of dysfunction.  He provides practical solutions for a prosperous future, even in light of the increasing regulatory constraints, restrictions on marketing and sales, and the increasing demands of a cost conscious market with its own challenges yet to be imposed by healthcare reform.

The author provides an insider’s perspective with unique insights into the unintended consequences of the industry’s rapid growth and explores why some Big Pharma companies may be too big.  Much like his blog, this 180 page book is not an exposé but rather a hard hitting discussion of how the industry’s mistakes and poor decisions  have led to serious questions about its outdated business model, its long-term commercial viability, and the imbalance between corporate priorities for “profits and patients” that drive product sales but often put patient health and safety at risk.